|
| 37393191 | Thoughts about the evolution of cancer registries in France. | Eur Ann Otorhinolaryngol Head Neck Dis | 2024 |
| 36269935 | Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials. | J Clin Oncol | 2023 |
| 37639648 | Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. | J Clin Oncol | 2023 |
| 35051385 | Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis. | Lancet Oncol | 2022 |
| 35469702 | High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP Consortium. | Eur Urol | 2022 |
| 35934601 | Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN). | Eur Urol | 2022 |
| 32583038 | External evaluation of the Briganti nomogram to predict lymph node metastases in intermediate-risk prostate cancer patients. | World J Urol | 2021 |
| 34310202 | Short Androgen Suppression and Radiation Dose Escalation in Prostate Cancer: 12-Year Results of EORTC Trial 22991 in Patients With Localized Intermediate-Risk Disease. | J Clin Oncol | 2021 |
| 33999161 | Association of Increased Prostate-Specific Antigen Levels After Treatment and Mortality in Men With Locally Advanced vs Localized Prostate Cancer: A Secondary Analysis of 2 Randomized Clinical Trials. | JAMA Netw Open | 2021 |
| 32446863 | Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250]. | Eur Urol | 2020 |
| 31753752 | EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort<sup>â¿ </sup>: Under the Auspices of the EAU-ESMO Guidelines Committees. | Eur Urol | 2020 |
| 31718822 | Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. | Eur Urol | 2020 |
| 33144063 | Patterns of practice of androgen deprivation therapy combined to radiotherapy in favorable and unfavorable intermediate risk prostate cancer. Results of The PROACT Survey from the French GETUG Radiation Oncology group. | Cancer Radiother | 2020 |
| 30326032 | Association of Gleason Grade With Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-analysis. | JAMA Oncol | 2019 |
| 31740927 | EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committeesâ¿ . | Ann Oncol | 2019 |
| 31061801 | The role of radiotherapy in localised and locally advanced prostate cancer. | Asian J Urol | 2019 |
| 31061796 | Prostate cancer: On the road of progress. | Asian J Urol | 2019 |
| 27568654 | EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. | Eur Urol | 2017 |
| 28336078 | What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel. | Eur Urol | 2017 |
| 28126351 | The Benefits and Harms of Different Extents of Lymph Node Dissection During Radical Prostatectomy for Prostate Cancer: A Systematic Review. | Eur Urol | 2017 |
| 28490338 | International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer. | Health Qual Life Outcomes | 2017 |
| 29353974 | Outcome and prognostic factors in 110 consecutive patients with primary uterine leiomyosarcoma: A Rare Cancer Network study. | Chin J Cancer Res | 2017 |
| 28757301 | Quality of Life Outcomes after Primary Treatment for Clinically Localised Prostate Cancer: A Systematic Review. | Eur Urol | 2017 |
| 27591931 | EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. | Eur Urol | 2017 |
| 26691493 | Role of Hormonal Treatment in Prostate Cancer Patients with Nonmetastatic Disease Recurrence After Local Curative Treatment: A Systematic Review. | Eur Urol | 2016 |
| 26666365 | Prostate cancer: Cardiac mortality associated with ADT plus radiotherapy. | Nat Rev Urol | 2016 |
| 27743921 | 24-gene predictor of response to postoperative irradiation. | Lancet Oncol | 2016 |
| 26976418 | Short Androgen Suppression and Radiation Dose Escalation for Intermediate- and High-Risk Localized Prostate Cancer: Results of EORTC Trial 22991. | J Clin Oncol | 2016 |
| 25435968 | Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer. | Oncol Lett | 2015 |
| 26460877 | Re: Adverse Effects of Androgen Deprivation Therapy and Strategies to Mitigate Them. | Eur Urol | 2015 |
| 26522335 | Hypofractionation for prostate cancer and PROs. | Lancet Oncol | 2015 |
| 27141392 | Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm. | Oncoimmunology | 2015 |
| 23522771 | The potential impact of adjuvant radiation therapy on urinary continence recovery after radical prostatectomy. | Eur Urol | 2014 |
| 26461606 | [Not Available]. | Prog Urol | 2014 |
| 25286905 | Results of a cohort of 200 hormone-naïve consecutive patients with prostate cancer treated with iodine 125 permanent interstitial brachytherapy by the same multidisciplinary team. | Cancer Radiother | 2014 |
| 25192626 | Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how? | Cancer Radiother | 2014 |
| 24820932 | Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities. | Eur J Cancer | 2014 |
| 24321502 | EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. | Eur Urol | 2014 |
| 24440473 | Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study. | Lancet Oncol | 2014 |
| 24207135 | EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. | Eur Urol | 2014 |
| 23972524 | Early salvage radiotherapy following radical prostatectomy. | Eur Urol | 2014 |
| 23265386 | Adjuvant or immediate external irradiation after radical prostatectomy with pelvic lymph node dissection for high-risk prostate cancer: a multidisciplinary decision. | Eur Urol | 2013 |
| 23915463 | Words of wisdom: Re: High-risk prostate cancer treated with pelvic radiotherapy and 36 versus 18 months of androgen blockade: results of a phase III randomized study [abstract 3]. | Eur Urol | 2013 |
| 23673512 | High-risk prostate cancer: combination of high-dose, high-precision radiotherapy and androgen deprivation therapy. | Curr Opin Urol | 2013 |
| 23707151 | Quality assurance of the EORTC 22043-30041 trial in post-operative radiotherapy in prostate cancer: results of the Dummy Run procedure. | Radiother Oncol | 2013 |
| 23540845 | Postoperative radiotherapy for high-risk prostate cancer - Authors' reply. | Lancet | 2013 |
| 21144766 | Combined hormone therapy and radiation therapy for locally advanced prostate cancer. | Crit Rev Oncol Hematol | 2012 |
| 23084481 | Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). | Lancet | 2012 |
| 22906671 | Development of a novel robot for transperineal needle based interventions: focal therapy, brachytherapy and prostate biopsies. | J Urol | 2012 |
| 22552217 | The moving landscape of locally advanced prostate cancer: combination of external irradiation and endocrine treatment and/or multimodal approach. | Eur Urol | 2012 |